Professor Mingguang He, Chief Medical Officer of Eyerising International has issued a statement in response to a study published in JAMA Ophthalmology.1 The Brief
Rayner is promising to “decode” the first peer-reviewed clinical paper on the RayOne Galaxy intraocular lens (IOL) in less than 15 minutes, with a
Johnson and Johnson Vision has released three-year data for Acuvue Abiliti 1‑Day soft therapeutic lenses for myopia management (Abiliti 1-Day).
Rayner has secured Medical Device and Human Tissue Advisory Committee (MDHTAC) acceptance and Prostheses List (PL) reimbursement for RayOne Galaxy, effective 1 March 2026.
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
